Elo Mutual Pension Insurance Co Trims Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Elo Mutual Pension Insurance Co reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,663 shares of the company's stock after selling 1,005 shares during the period. Elo Mutual Pension Insurance Co's holdings in HCA Healthcare were worth $5,302,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Congress Wealth Management LLC DE raised its stake in shares of HCA Healthcare by 3.4% in the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after buying an additional 34 shares in the last quarter. Evergreen Private Wealth LLC lifted its stake in HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after buying an additional 35 shares during the period. Mediolanum International Funds Ltd boosted its position in shares of HCA Healthcare by 0.3% during the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after purchasing an additional 36 shares in the last quarter. Prairie Wealth Advisors Inc. grew its position in shares of HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after purchasing an additional 40 shares during the period. Finally, Whittier Trust Co. lifted its holdings in shares of HCA Healthcare by 3.6% in the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after purchasing an additional 41 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.30% of the company's stock.

Analyst Ratings Changes

Several research firms have issued reports on HCA. Morgan Stanley dropped their price objective on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a research note on Tuesday, December 17th. Royal Bank of Canada dropped their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research report on Monday, January 27th. Cantor Fitzgerald reissued an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Truist Financial cut their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Finally, KeyCorp reduced their price target on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $385.67.

HCA Healthcare Trading Up 0.4 %

Shares of HCA traded up $1.54 during trading hours on Tuesday, reaching $347.09. 241,945 shares of the company traded hands, compared to its average volume of 1,342,530. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a market capitalization of $85.45 billion, a price-to-earnings ratio of 15.76, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company's fifty day moving average price is $325.24 and its two-hundred day moving average price is $340.60.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the firm posted $5.90 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.83%. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio (DPR) is currently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.